Mustang Bio, Inc. (MBIO)
0.5412
0.00 (0.00%)
USD |
NASDAQ |
Sep 08, 16:00
Mustang Bio 1 Year Total Returns (Daily) : -60.21% for Sept. 8, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| September 08, 2026 | -60.21% |
| September 04, 2026 | -63.07% |
| September 03, 2026 | -63.64% |
| September 02, 2026 | -64.51% |
| September 01, 2026 | -63.70% |
| August 31, 2026 | -64.40% |
| August 28, 2026 | -65.20% |
| August 27, 2026 | -64.05% |
| August 26, 2026 | -62.91% |
| August 25, 2026 | -64.16% |
| August 24, 2026 | -66.59% |
| August 21, 2026 | -65.76% |
| August 20, 2026 | -65.28% |
| August 19, 2026 | -65.00% |
| August 18, 2026 | -66.27% |
| August 17, 2026 | -66.42% |
| August 14, 2026 | -66.66% |
| August 13, 2026 | -68.24% |
| August 12, 2026 | -64.39% |
| August 11, 2026 | -65.45% |
| August 10, 2026 | -64.45% |
| August 07, 2026 | -60.48% |
| August 06, 2026 | -60.87% |
| August 05, 2026 | -61.98% |
| August 04, 2026 | -60.66% |
| Date | Value |
|---|---|
| August 03, 2026 | -60.78% |
| July 31, 2026 | -62.73% |
| July 30, 2026 | -61.19% |
| July 29, 2026 | -64.42% |
| July 28, 2026 | -66.77% |
| July 27, 2026 | -70.68% |
| July 24, 2026 | -72.32% |
| July 23, 2026 | -72.59% |
| July 22, 2026 | -71.72% |
| July 21, 2026 | -70.26% |
| July 20, 2026 | -70.09% |
| July 17, 2026 | -72.92% |
| July 16, 2026 | -70.84% |
| July 15, 2026 | -73.56% |
| July 14, 2026 | -72.63% |
| July 13, 2026 | -74.95% |
| July 10, 2026 | -73.75% |
| July 09, 2026 | -76.21% |
| July 08, 2026 | -74.44% |
| July 07, 2026 | -78.75% |
| July 06, 2026 | -40.35% |
| July 02, 2026 | -43.31% |
| July 01, 2026 | -65.79% |
| June 30, 2026 | -26.50% |
| June 29, 2026 | -31.41% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 8.63% |
| Alnylam Pharmaceuticals, Inc. | -42.84% |
| Anika Therapeutics, Inc. | 135.3% |
| Savara, Inc. | 43.64% |
| Vericel Corp. | 17.64% |